2019 annual financial data

Aptevo Therapeutics 2019 Financial results

Direct answer

Revenue was 32,424,000 USD.

Operating income was -40,962,000 USD and net income was -44,698,000 USD.
Operating cash flow was -42,383,000 USD.

Get free Aptevo Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
32,424,000 USD
Operating income
-40,962,000 USD
Net income
-44,698,000 USD
Operating cash flow
-42,383,000 USD